title: Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.
abstract: We have previously located a major neutralization site of the fusion protein of respiratory syncytial virus (RSV) in the polypeptide region extending from amino acids Ile221 to Glu232. In this report, 8 peptides corresponding to the six major hydrophilic regions of the F1 subunit were selected to analyse their immunogenic and protective capacities as well as their ability to block the high neutralization activities of 4 monoclonal antibodies (MAbs). Only 5 of the 8 peptides tested induced specific antibodies while all induced an in vitro interleukin-2 response of splenocytes from immunized mice. Peptide 3 (Ile221-Phe237) was able to elicit neutralizing antibodies, confirming our previous hypothesis concerning the location of a neutralization site. However, immunization with the latter did not induce significant reduction of virus in lungs of BALB/c mice upon challenge, probably due to an inadequate level of circulating neutralizing antibodies. Interestingly, peptides 2 (Asn216-Glu232), 3 (Ile221-Phe237), and 5 (Ser275-Ile288) blocked in vitro neutralization by four different F1 specific MAbs. A hypothesis is proposed to explain these results.
authors.affiliation: Centre de Recherche en Virologie, Institut Armand-Frappier, Université du Québec, Laval, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Trudel
authors.forename: E J
authors.initials: EJ
authors.lastname: Stott
authors.forename: G
authors.initials: G
authors.lastname: Taylor
authors.forename: D
authors.initials: D
authors.lastname: Oth
authors.forename: G
authors.initials: G
authors.lastname: Mercier
authors.forename: F
authors.initials: F
authors.lastname: Nadon
authors.forename: C
authors.initials: C
authors.lastname: Séguin
authors.forename: C
authors.initials: C
authors.lastname: Simard
authors.forename: M
authors.initials: M
authors.lastname: Lacroix
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral / Q000096:biosynthesis / Q000276:immunology; D000918:Antibody Specificity; D000956:Antigens, Viral / Q000138:chemical synthesis / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000276:immunology; D015707:HN Protein; D007376:Interleukin-2 / Q000096:biosynthesis; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D010253:Respirovirus Infections / Q000517:prevention & control*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins / Q000138:chemical synthesis / Q000276:immunology; D014764:Viral Proteins; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D000956:Antigens, Viral; D000939:Epitopes; D015707:HN Protein; D007376:Interleukin-2; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins; D014764:Viral Proteins; D014765:Viral Vaccines; C116204:attachment protein G